Biogennix Gains Additional FDA Clearance for Agilon Moldable Bone Graft
Biogennix received FDA 510(k) clearance to market Agilon™ moldable bone graft for use in posterolateral spine procedures when mixed with autograft....
Biogennix received FDA 510(k) clearance to market Agilon™ moldable bone graft for use in posterolateral spine procedures when mixed with autograft....
DiscGenics completed enrollment in its Phase I/II first-in-human U.S. clinical study of injectable disc cell therapy to treat degenerative disc disease....
Biocomposites commenced U.S. launch of STIMULAN® Rapid Cure 3cc synthetic calcium sulfate, designed specifically for smaller voids in the foot and ankle....
Bone Solutions announced successful implantation in over 1,000 cases with magnesium-based OsteoCrete® bone void filler....
Results from clinical study of BBS-Bioactive Bone Substitutes' ARTEBONE® paste showed a fusion rate comparable with that of autograft....
Onkos Surgical is marketing GenVieâ„¢ magnesium-based bone void filler through a distribution agreement with Bone Solutions....
GreenBone Ortho received approval under the CE Mark for GreenBone Bone Substitute™....
Royal Biologics launched MAGNUS, a viable cellular bone allograft that uses a DMSO-free cryoprotectant....
Preclinical animal study results indicate that Bone Biologics' rhNELL-1 growth factor effectively promoted bone formation in a spine model. ...
Carmell Therapeutics announced FDA clearance of an Investigational New Drug application for the company’s Bone Healing Accelerant and enrollment in...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.